EXG | GNT | EXG / GNT | |
Gain YTD | 4.068 | 11.551 | 35% |
Net Assets | 2.83B | 104M | 2,721% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 19.00 | 81.00 | 23% |
Yield | 1.00 | 5.83 | 17% |
Fund Existence | 18 years | 14 years | - |
EXG | GNT | |
---|---|---|
RSI ODDS (%) | 4 days ago72% | 3 days ago79% |
Stochastic ODDS (%) | 3 days ago83% | 3 days ago80% |
Momentum ODDS (%) | 3 days ago74% | 3 days ago81% |
MACD ODDS (%) | 3 days ago74% | 3 days ago82% |
TrendWeek ODDS (%) | 3 days ago75% | 3 days ago77% |
TrendMonth ODDS (%) | 3 days ago74% | 3 days ago89% |
Advances ODDS (%) | N/A | N/A |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 3 days ago85% | 3 days ago90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IVITX | 23.18 | 0.36 | +1.58% |
VY® Invesco Growth and Income S2 | |||
LGOQX | 22.02 | 0.30 | +1.38% |
Lord Abbett Growth Opportunities R2 | |||
GOFCX | 24.03 | 0.30 | +1.26% |
Pioneer Select Mid Cap Growth C | |||
ACILX | 28.88 | 0.36 | +1.26% |
American Century Heritage G | |||
SBHIX | 23.80 | 0.24 | +1.02% |
Saratoga Health & Biotechnology I |
A.I.dvisor tells us that EXG and AAPL have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXG and AAPL's prices will move in lockstep.
Ticker / NAME | Correlation To EXG | 1D Price Change % | ||
---|---|---|---|---|
EXG | 100% | +0.84% | ||
AAPL - EXG | 17% Poorly correlated | +1.91% | ||
MSFT - EXG | 10% Poorly correlated | +1.14% | ||
NVDA - EXG | 7% Poorly correlated | +3.97% | ||
ASML - EXG | 6% Poorly correlated | +1.63% | ||
GOOG - EXG | 4% Poorly correlated | +1.18% | ||
More |
A.I.dvisor tells us that GNT and GOLD have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNT and GOLD's prices will move in lockstep.